fashion -WSS

fashion

author：entertainment 2025-09-05 13:32:57 - browse：36

health care AI border between health care and tech — Adobe

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： What Kate Middleton's cancer revelation might teach the world

hotspot

WSS

What Kate Middleton's cancer revelation might teach the world

Pregnancy ages women, but effects reverse after delivery

Texas board proposes rules on abortion law emergency exemption

Medicare Advantage insurers pressure Biden for bigger payments

Ambulance rides for just $100? Advisers want major billing fixes

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

entertainment

fashion

leisure time

Virginia high school admissions case could be legal follow

Biotech investment managers search for lucrative opportunities

How one medical school became remarkably diverse

White House calls on federal agencies to crack down on AI abuses

Alkermes shareholders re

U.K. officials, researchers try to ease path for bespoke genetic treatments

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Adam's Take: Intra

In age of alternative facts, a scholarly course on calling out crap

Chinese researcher claims birth of first gene

focus

Mirador, a new biotech startup, launches with $400 million

Texas board proposes rules on abortion law emergency exemption

CRISPR technology availability, affordability needs to be expanded

The Sacklers, horror, and ‘The Fall of the House of Usher’

MoonLake credibility takes another hit with mid

MoonLake credibility takes another hit with mid

hotspot

hotspot

knowledge

focus